Macular Degeneration Association

Therapeutic Areas: Oncology | Hematology

Hematologic Neoplasms Clinical Trials

A listing of Hematologic Neoplasms medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Scottsdale Arizona 85259-5499

A clinical trial seeking patients for a research study for the treatment of Haematological Malignancy, Multile Pyeolma (SAR650984)

Scottsdale Arizona 85258

A Phase 1 clinical study for patients with Hematologic Neoplasms

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

California

Los Angeles California 90027

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

San Francisco California 94117

A clinical trial seeking patients for a research study for the treatment of Haematological Malignancy, Multile Pyeolma (SAR650984)

San Francisco California 94143

A Phase 1 clinical study for patients with Hematologic Neoplasms

District of Columbia

Washington District of Columbia 20010

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

Georgia

Atlanta Georgia 30322

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

Maryland

Baltimore Maryland 21231

A clinical trial to evaluate treatments using CC-486 for patients with Hematologic Neoplasm or Neoplasms

Baltimore Maryland 21287

A Phase 1 clinical study for patients with Hematologic Neoplasms

Massachusetts

Boston Massachusetts 02215

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

Boston Massachusetts 02215

A Phase 1 clinical study for patients with Hematologic Neoplasms

Michigan

Detroit Michigan 48201

A Phase 1 clinical study for patients with Hematologic Neoplasms

Missouri

St. Louis Missouri 63110

A Phase 1 clinical study for patients with Hematologic Neoplasms

New Jersey

Hackensack New Jersey 07601

A clinical trial seeking patients for a research study for the treatment of Haematological Malignancy, Multile Pyeolma (SAR650984)

New Brunswick New Jersey 08903

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

New York

UPDATED

New York New York 10032

A clinical research study of BAY1251152 for the treatment of Hematologic Neoplasms

UPDATED

New York New York

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

Bronx New York 10467

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

New York New York 10021

A Phase 1 clinical study for patients with Hematologic Neoplasms

Oregon

Portland Oregon 97239

A Phase 1 clinical study for patients with Hematologic Neoplasms

South Carolina

Greenville South Carolina 29605

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Tennessee

Nashville Tennessee 37232

A clinical trial seeking patients for a research study for the treatment of Haematological Malignancy, Multile Pyeolma (SAR650984)

Nashville Tennessee 37232-6307

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Texas

Dallas Texas 75390

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

Houston Texas 77030

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

Houston Texas 77030

A clinical trial to evaluate treatments using CC-486 for patients with Hematologic Neoplasm or Neoplasms

Houston Texas 77030

A Phase 1 clinical study for patients with Hematologic Neoplasms

Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

San Antonio Texas 78229

A Phase 1 clinical study for patients with Hematologic Neoplasms

Utah

Salt Lake City Utah 84112-5550

A clinical trial seeking patients for a research study for the treatment of Haematological Malignancy, Multile Pyeolma (SAR650984)

Washington

Seattle Washington 98109

A Phase 1 clinical study for patients with Hematologic Neoplasms

Australia

UPDATED

Bedford Park

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

UPDATED

Darlinghurst

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

UPDATED

Woolloongabba

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

Israel

UPDATED

Haifa

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

UPDATED

Jeursalem

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

UPDATED

Ramat Gan

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

UPDATED

Tel Aviv

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

Poland

UPDATED

Chorzow

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

UPDATED

Gdansk

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

UPDATED

Krakow

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

UPDATED

Wroclaw

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

Spain

UPDATED

Barcelona

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

UPDATED

Madrid

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

UPDATED

Salamanca

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

Turkey

UPDATED

Ankara

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

UPDATED

Istanbul

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

UPDATED

İzmir

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies